Recap: Cerus Q2 Earnings

Shares of Cerus CERS rose in after-market trading after the company reported Q2 results.

Quarterly Results

Earnings per share were unchanged 0.00% over the past year to ($0.09), which were in line with the estimate of ($0.09).

Revenue of $31,484,000 up by 46.42% year over year, which beat the estimate of $31,480,000.

Outlook

Cerus hasn't issued any earnings guidance for the time being.

The upcoming fiscal year's revenue expected to be between $118,000,000 and $122,000,000.

Details Of The Call

Date: Aug 03, 2021

Time: 04:30 PM

ET Webcast URL: https://edge.media-server.com/mmc/p/7ya9s2wv

Price Action

Company's 52-week high was at $8.87

52-week low: $4.67

Price action over last quarter: down 3.65%

Company Profile

Cerus Corp is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Posted In: BZI-RecapsEarnings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.